Integra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $250.3 million versus the consensus estimate of $249.3 million.

GUIDANCE:

Integra LifeSciences sees FY2016 EPS of $3.47-$3.53, versus the consensus of $3.48.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.